← SynDRA
ZALCITABINE
SynDRA canonical compound SYN0002222 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | nucleoside reverse transcriptase inhibitor |
|---|
| Indication | human immunodeficiency virus (HIV-1) |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- nucleoside reverse transcriptase inhibitor
- HIV RT INHIBITOR
- pol INHIBITOR
- HSV UL30 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD2
- CXCR4
- NR3C1
- NPY1R
- NFKB1
- MLNR
- MC4R
- MC3R
- MAPT
- ADORA1
- MAPK1
- MAOA
- LMNA
- KCNH2
- HTR3A
- HTR2C
- HTR2B
- NR1I2
- OPRD1
- HTR1A
- OPRK1
- TDP1
- TBXA2R
- SLC6A4
- SLC6A3
- SLC6A2
- SLC47A1
- SLC29A1
- SLC22A6
- SAMHD1
- PTGS2
- POLB
- PGR
- PDE4D
- PDE3A
- OPRM1
- HTR2A
- HRH2
- ADORA2A
- AGTR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antimetabolites
- Antiviral Agents
- Enzyme Inhibitors
- Noxae
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- HIVID
- Ro 24-2027/000
- hivid
- dideoxycytidine
- Zalcitabina
- Ddc (ddc)
- Dideoxycytidine
- Zalcitabine (dideoxycytidine,ddc)
- NSC-606170
- RO-24-2027/000
- RO-24-2027000
- RO-242027000
- Ro-24-2027-000
- Hivid
- 2',3'-DIDEOXYCYTIDINE
- ddCyd
- ddC
- Cytidine, 2',3'-dideoxy-
- Zalcitibine
- 2,3-dideoxycytidine
- NSC 606170
- UNII-6L3XT8CB3I
- CCRIS 692
- HSDB 7156
- C9H13N3O3
- CHEMBL853
- BRN 0654956
- 6L3XT8CB3I
- CHEBI:10101
- WREGKURFCTUGRC-POYBYMJQSA-N
- MFCD00012188
- D 5782
- DDC (DDC)
- DdC & Interferon alpha
- DdC & sCD4
- DdC (Antiviral)
- Hivid (TN)
- Hivid(TM)
Look up ZALCITABINE in the interactive SynDRA portal →